Public Calendar: February 16 - 22, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Sara Brenner, M.D., M.P.H., Acting Commissioner for Food and Drugs
No Significant Event
Official Name: Ritu Nalubola, Ph.D., Acting Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Angelique Hebert, Acting Deputy Commissioner for Operations
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 02/18/2025
Location: Virtual
Subject: FDA - American Society of Gene and Cell Therapy Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the American Society of Gene and Cell Therapy
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Robert F. Foster, J.D., Chief Counsel
No Significant Event